flow trial semaglutide kidney outcomes hazard ratio 0.76 nejm 2024 Patients with type 2 #diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. ⁣ ⁣ Whether treatment with would mitigate these risks is unknown. ⁣ ⁣ Preventing chronic kidney disease and

At full doses, some studies found that these medications may influence aging at both a cellular and systemic level by improving metabolic efficiency, reducing inflammation and shielding the body from the biological stressors that accelerate age-related decline

Your starting tablet dose will depend on which injection dose you're currently on

Once you've injected the delayed dose, resume your normal weekly schedule from that new injection datethis becomes your new anchor day going forward for the next week

The starting dose of tirzepatide is intentionally low to minimize the risk of gastrointestinal side effects

The product is working, I am losing weight." "The monthly check in with the medical team is great

But, as with anything that promises dramatic results, there are questions